ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,158,519 | +18.7% | 4,095,745 | +34.4% | 6.01% | +19.9% |
Q2 2023 | $93,666,286 | -14.7% | 3,047,049 | 0.0% | 5.01% | +8.0% |
Q1 2023 | $109,785,175 | +40.7% | 3,047,049 | +54.3% | 4.64% | +41.5% |
Q4 2022 | $78,037,180 | +5.4% | 1,974,625 | +7.2% | 3.28% | +6.6% |
Q3 2022 | $74,040,000 | -42.8% | 1,842,718 | -40.1% | 3.07% | -37.5% |
Q2 2022 | $129,420,000 | +64.0% | 3,078,506 | +52.0% | 4.92% | +104.1% |
Q1 2022 | $78,918,000 | +0.7% | 2,025,610 | +3.0% | 2.41% | +58.8% |
Q4 2021 | $78,396,000 | +42.0% | 1,967,273 | +28.8% | 1.52% | +63.2% |
Q3 2021 | $55,218,000 | +84.7% | 1,527,900 | +109.5% | 0.93% | +108.1% |
Q2 2021 | $29,897,000 | -28.4% | 729,377 | -23.8% | 0.45% | -27.6% |
Q1 2021 | $41,747,000 | -76.5% | 957,053 | -73.1% | 0.62% | -75.7% |
Q4 2020 | $178,024,000 | +50.5% | 3,556,933 | +26.5% | 2.54% | +19.3% |
Q3 2020 | $118,317,000 | +13.2% | 2,812,381 | +30.6% | 2.13% | -5.1% |
Q2 2020 | $104,528,000 | – | 2,153,000 | – | 2.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |